Berodual®

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease

CompletedNCT02231437

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1999-01-31Updated: 2014-09-04

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

CompletedNCT02232594

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-01-31Updated: 2014-09-05